Throughout the last three months, 4 analysts have evaluated Agilent Technologies (NYSE:A), offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
The 12-month price targets, analyzed by analysts, offer insights with an average target of $146.25, a high estimate of $160.00, and a low estimate of $135.00. Marking an increase of 1.74%, the current average surpasses the previous average price target of $143.75.
Deciphering Analyst Ratings: An In-Depth Analysis
The standing of Agilent Technologies among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Key Insights:
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Agilent Technologies's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on Agilent Technologies analyst ratings.
Discovering Agilent Technologies: A Closer Look
Agilent Technologies: Delving into Financials
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Challenges: Agilent Technologies's revenue growth over 3 months faced difficulties. As of 31 July, 2024, the company experienced a decline of approximately -5.62%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: Agilent Technologies's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 17.87% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 4.65%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.58%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.5.
How Are Analyst Ratings Determined?
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
